Newsletter 2010 - Cochrane Incontinence Group - The Cochrane

Edition 13 1 June 2010

C OCHRANEEdition 13 INCONTINENCE REVIEW GROUP June 2010

In this issueCochrane Collaboration on Facebookand twitter ....................................................................1Editorial Team News ..................................................2What is a Cochrane Diagnostic Test AccuracyReview? ..........................................................................3The Cochrane Journal Club.......................................4Profile of one of our editors, Mandy Fader.........5New terminology for Urinary Incontinence .........5Workshops offered by Cochrane Centresin 2010 ..........................................................................6Online Learning Resources........................................6Cochrane Collaboration News...................................6Abstract of a newly published review: Minimallyinvasive synthetic suburethral sling operationsfor stress urinary incontinence in women.............7In The Cochrane Library...........................................8Joint Annual Meeting of the InternationalIncontinence Society (ICS) and theInternational Urogynaecological Association(IUGA)..........................................................................10Joint Colloquium of the Cochrane and CampbellCollaborations .............................................................10The Editorial Team and Cochrane CentresWorldwide ....................................................................11Contact details form ................................................12

The Cochrane Collaboration is an international not-for-profit and independent organization, dedicatedto making up-to-date, accurate information aboutthe effects of healthcare readily availableworldwide. It produces and disseminates systematicreviews of healthcare interventions and promotesthe search for evidence in the form of clinical trialsand other studies of interventions. The CochraneIncontinence Group is a Collaborative Review Group(CRG) of the Cochrane Collaboration.

We undertake systematic reviews of randomisedcontrolled trials on different interventions designedto prevent or treat incontinence and relatedconditions, or aid rehabilitation. The group isconcentrating on interventions where incontinenceor pelvic floor dysfunction is the primary problem.

The problems covered include urinary and faecalincontinence, enuresis, day-time wetting in children,encopresis, postprostatectomy incontinence, use ofurinary catheters including catheter-related urinarytract infections (but not other urinary infections),enterocutaneous and enterovesical fistulae,neurogenic incontinence and retention, interstitialcystitis, postoperative urinary retention and pelvicorgan prolapse.

What do we do?

Sign up for Facebook to connect withThe Cochrane Collaboration:www.facebook.com/group.php?gid=63721740498

Twitter is a free service that letsyou keep in touch with peoplethrough the exchange of quick,frequent answers to one simplequestion: What's happening? Jointoday to start receivingcochranecollab's tweets.www.twitter.com/CochraneCollab

Cochrane Collaboration onFacebook and twitter

THE COCHRANECOLLABORATION

www.incontinence.cochrane.org

Visit the Cochrane IncontinenceReview Group online at

www.cochrane.org

Visit the Cochrane Collaborationonline at

Cochrane Incontinence Review Group


June Cody (Managing Editor), Sheila Wallace (TrialsSearch Coordinator) and Cathryn Glazener (JointCo-ordinating Editor) attended the 34th AnnualMeeting of the International UrogynaecologicalAssociation (IUGA), at Como, Italy, in June lastyear. Our group had an exhibition stand and we metmany of our reviewers.

The 17th Cochrane Colloquium was held last year inOctober, in Singapore.

At the Welcome ReceptionLeft to right: Sheila Wallace, James N’Dow,

Luke Vale and June Cody.

Members of our Editorial team attended to learnmore about systematic review methodology,consumer and policy maker issues, widening accessto and participation in Cochrane and enhancing theuse of evidence in health care decisions.

At the Farewell DinnerLeft to right: June Cody, Peter Herbison,Marie Carmela Lapitan and Brian Buckley.

The group is taking part in a pilot on workflowsystems in Archie. Workflows enable editorial staffto monitor and manage the progress of reviews. Thesystem is being introduced in three pilot stages.

June Cody (Managing Editor), Sheila Wallace (TrialsSearch Co-ordinator) and Jonathan Cook(Statistical Editor) attended the 15th AnnualMeeting of UK and Ireland-based Contributors toThe Cochrane Collaboration, in Cardiff in March.The meeting provides an opportunity for UK andIreland based members actively involved with TheCochrane Collaboration to get together to learn,debate and network.

Peter Herbison, who is one of our editors, fromDunedin in New Zealand, visited the Editorial Base inMarch this year. Peter gave a very interestingpresentation to staff from the Health ServicesResearch Unit and Academic Urology Unit, of theUniversity of Aberdeen. The presentation was titled‘Lessons from a systematic review of anticholinergicdrug treatment of overactive bladder’.

Peter Herbison’s visit to the Editorial BaseLeft to right: James N’Dow, Adrian Grant,

Jonathan Cook, Cathryn Glazener, Peter Herbison,June Cody, Bronwyn Davidson and Sheila Wallace.

The editorial base staff will be attending aDiagnostic Test Accuracy training day in May. Thiswill be lead by Professor Jon Deeks of theDiagnostic Test Accuracy Working Group entity.

Editorial team news



Cochrane diagnostic test accuracy (DTA) reviewsinvestigate the diagnostic accuracy of a diagnostictest or test combinations. They are designed tofacilitate the choices that doctors, patients, policymakers and others face regarding diagnosticproblems in health care. Cochrane DTA reviews arenot based on randomized controlled trials, butmainly on cross sectional studies.

Cochrane DTA reviews have the following generalfeatures in common with Cochrane reviews ofinterventions:

• A structured format helps the reader to findhis/her way around the review easily.

• A detailed methods section allows the reader toassess whether the review was done in such away as to justify its conclusions.

• The quality of clinical studies to be incorporatedinto a review is carefully considered, usingpredefined criteria.

• A thorough and systematic search strategy,which includes searches for unpublished and non-English records, aims to provide as complete apicture as possible to try to answer the questionconsidered.

• If the data collected in a review are ofsufficient quality and similar enough, they aresummarised statistically in a meta-analysis,which generally provides a better overallestimate of a clinical effect than the resultsfrom individual studies.

• Multinational editorial teams try to ensure thata review is applicable in different parts of theworld.

• Reviews are updatable. Results from newlycompleted or identified studies can beincorporated into the review after publication.Additionally, readers can send in comments andcriticisms to any review, and reviews may bechanged accordingly to improve their quality.

What is a Cochrane Diagnostic Test Accuracy (DTA) Review

STRUCTURE OF A COCHRANE DIAGNOSTICTEST ACCURACY REVIEW

Cochrane DTA reviews are structured reports thatprovide the rationale for and methods used toprepare the review together with a synthesis of theevidence found and implications for clinicians andpolicy makers. They contain:

1. Structured Abstract – a structured summary ofthe review, subdivided into sections. Theabstract appears on the medical bibliographicdatabase MEDLINE.

2. Background – this gives an introduction to thequestion considered, including, for example,details on causes and incidence of a givenproblem, uncertainties about managementoptions, the tests under evaluation, thereference standard by which the true status ofthe patient is verified etc… and other aspectsthat are also important, is the place of the testsunder evaluation in practice and consequences offalse positive and false negative test results.

3. Objectives – short statement of the aim of thereview.

4. Selection criteria – brief description of the mainelements of the question under consideration.This is subdivided into:

a. Types of studies – for example, consecutiveseries of patients, or case-control studies;

b. Participants – the population of interest. Thissection may include details of the participantsfor whom the test would be applicable, includingany restrictions on diagnoses, age groups andsettings;

c. Index tests, which are tests under evaluation;

d. Target condition, which is a particular disease ordisease stage that the index test is intended toidentify. Tests may occasionally be used todifferentiate between several target conditions.



e. Reference standards – the tests (‘goldstandard’) that are considered appropriate toestablish the presence or absence of the targetcondition in the tested population.

5. Search strategy for identification of studies –details of how an exhaustive identification ofrelevant information was attempted, includingdetails of searches of electronic databases,searches for unpublished information,handsearching of journals or conferenceproceedings, searching of reference lists ofrelevant articles, etc…

6. Methods of the review – description of howstudies eligible for inclusion in the review wereselected, how their quality was assessed, howdata were extracted from the studies, how datawere analysed, whether any subgroups werestudied or whether any sensitivity analyses werecarried out, etc…

7. Description of studies – how many studies werefound, what were their inclusion criteria, how bigwere they, etc..?

8. Methodological quality of included studies – werethere any reasons to doubt the conclusions ofany studies because of concerns about the studyquality? Main quality issues involve theverification of the test results, the participantsin the study and how they were recruited, andblinding of assessors.

9. Results – what do the data show? The resultssection may be accompanied by a graph, even ifthere is no meta-analysis. These graphs mayshow the distribution of sensitivity andspecificity of the included studies. If meta-analysis was appropriate, these graphs may showa curve or a summary point estimate (withconfidence elipse around it).

10. Discussion – interpretation and assessment ofresults.

11. Authors' conclusions – subdivided intoImplications for practice and Implications forresearch.

The DTAWorking Group has given us permissionto re-publish this article in our newsletter.

Citation: www3.interscience.wiley.com/homepages/106568753/what_diagnostic.pdf

Cochrane Journal Club

Cochrane Journal Club is a free, monthly publicationthat introduces a recent Cochrane review, togetherwith relevant background information, a podcastexplaining the key points of the review, discussionquestions to help you to explore the review methodsand findings in more detail, and downloadablePowerPoint slides containing key figures and tables.You can even contact the review authors with yourquestions.

Aimed at trainees, researchers and clinicians alike,every Cochrane Journal Club article is speciallyselected from the hundreds of new and updatedreviews published in each issue of The CochraneLibrary representing diverse clinical topics, andeach one focuses on a review of special interest,such as practice-changing reviews, new methodologyand evidence-based practice.

One of our reviews was published in the CochraneJournal Club last year:Minimally invasive synthetic suburethral slingoperations for stress urinary incontinence in women:as effective as open surgery? Ogah J, Cody JD,Rogerson L.

To access this review and listen to the podcast goto: www.cochranejournalclub.com/sling-operations-clinical/

A podcast of our review on Oestrogen therapy forurinary incontinence in post-menopausal women(Cody JD, Richardson K, Moehrer B, Hextall A,Glazener CMA) can be accessed on the linkwww.cochrane.org/podcasts/

To access the Cochrane Journal Club go to:www.cochranejournalclub.com



Whilst doing ‘agency’ in Knightsbridge as a newlyqualified nurse in the early 1980s, I accompanied mypatient – an elderly man who had had a stroke andwas incontinent of urine - to the continence serviceat St. Pancras hospital. His life was transformed byadvice from James Malone-Lee and Christine Nortonto start intermittent catheterisation. Sooncontinent during the day, night-time continencefollowed once I had taught his wife (in her 80s) tocatheterise him last thing before going to bed. Withno need for a costly night nurse and no concernsabout wet trousers shopping at Harrods was rightlyrestored!

Thus I was converted to the cause of continence andsoon became part of the St. Pancras/UCL team tocarry out the first (of many) clinical trials ofcontinence products. Joined the following year byAlan Cottenden I became much absorbed in testingand working on prototype designs which allowed meto develop some rare skills (e.g. peeing pre-setvolumes into different products) which I am stillhoping will equip me for a highly paid job (nosuggestions please).

Working as a community continence advisor betweenresearch jobs exposed the reality of living withdisabilities and intractable incontinence – thesquelching carpets, damp chairs, knock-out smellsand distress of trying to manage incontinence withinadequate containment products sealed my loyaltyto working at the wettest end of incontinence.There is much incontinence which is resolutelyunamenable to surgical, pharmaceutical, physical orbehavioural treatments and better products areneeded.

My thesis on the effects of different pad changingregimens on skin health and sleep was a fine exampleof equipoise – frequently expressed by nursinghome staff -‘pointless – obviously you need to changepads at night otherwise you get skin problems’;‘waste of money – obviously residents should nothave their sleep disturbed’. Recruiting residents tohave measurements taken on their bottoms at 5am(not to mention trudging round the Homes with theequipment in the early hours) has also helped me tooffer nurse researchers, realistic guidance on thefeasibility of their over-ambitious projects (so areyou seriously expecting night nurses to keep diariesand collect stool samples?).

From UCL to the University of Southampton after astring of trials on pads, catheters, catheter valves,leg bags, sheaths and urinals I joined forces withKathy Getliffe and more recently have focused onlong-term catheters, catheter valves and bladderhealth, and the efficacy and acceptability of devicesfor men with incontinence after prostate cancer.Aware that not everyone shares a burning interestin continence products Cochrane reviews are anexcellent way of bringing attention to an importantbut sometimes neglected area of continenceresearch. Having completed three reviews ofproducts I became an Editor in 2008.

Mandy Fader

Profile of one of our editors, Mandy Fader

New terminology forUrinary Incontinence

We would like to draw your attention to thepublication of an update of the terminology used inurinary incontinence. Both the InternationalContinence Society (ICS) and the InternationalUrogynecological Association (IUGA) advocate itsuse and jointly published this paper in recognition.We would be grateful if all Cochrane review authorswould use this when updating or writing new reviews.

References:B. T. Haylen, Ridder D. De, R. M. Freeman, S. E. Swift, B.Berghmans, J. Lee, et al. An International UrogynecologicalAssociation (IUGA)/International Continence Society (ICS)joint report on the terminology for female pelvic floordysfunction. Neurourol Urodyn 29 (1):4-20, 2010.

B. T. Haylen, Ridder D. De, R. M. Freeman, S. E. Swift, B.Berghmans, J. Lee, et al. An International UrogynecologicalAssociation (IUGA)/International Continence Society (ICS)joint report on the terminology for female pelvic floordysfunction. Int Urogynecol J Pelvic Floor Dysfunct 21 (1):5-26, 2010.



UK and Ireland:05 May: Conducting Systematic Reviews of

Complex Interventions – Oxford.11 - 12 May: Review Updating Course – Oxford.18 - 21 May: The Nottingham Systematic

Review Course 2010.08 Jun: Developing a Protocol for a Review

- Glasgow.09 June: Introduction to Analysis - Glasgow.16 June: Advanced Topics in the Analysis

and Reporting of SystematicReviews – Oxford.

28 Sept: Developing a Protocol for a Review– York.

29 Sept: Introduction to Analysis - York.

North American region Workshops:03 - 14 May: Systematic Review Course -

Montreal, QC, Canada.

Asia-Pacific region workshops:7 – 8 June: Developing a Protocol and

Introduction to Analysis Workshop- Melbourne, Australia.

21 – 22 June: Developing a Protocol andIntroduction to Analysis Workshop- Gold Coast, Australia.

23-24 June: Cochrane Review Completion andUpdate Program - Brisbane,Australia.

7 July: Cochrane Review Completion andUpdate Program - Sydney,Australia.

8 – 9 July: Developing a Protocol andIntroduction to Analysis Workshop- Sydney, Australia.

3 - 4 Aug: Developing a Protocol andIntroduction to Analysis Workshop- Adelaide, Australia.

5 Aug: Cochrane Review Completion andUpdate Program - Adelaide,Australia.

For more information on further Cochraneworkshops and other evidence-based health careworkshops, go to the link below:http://www.cochrane.org/events/w-shops/all

The UK Cochrane Centre has worked in collaborationwith the University of Portsmouth to develop theOnline Learning Resources for Undertaking aSystematic Review. This project is partially fundedby The Cochrane Collaboration Opportunities Fundand is intended to enhance learning opportunitiesfor Cochrane Review Authors. It is based around anonline learning tool which incorporates the face-to-face training materials used by the UK CochraneCentre and complements The Cochrane Handbookfor Systematic Reviews of Interventions. Thefollowing five modules are currently available.

• Systematic reviews introduction• Meta-analysis introduction• Heterogeneity introduction• Searching for studies for a Cochrane review• Collecting data for a review• Writing a Protocol

These online materials are only available to UK andIreland-based Cochrane authors with an Archie log-in.

For more details go to:http://ukcc.cochrane.org/en/newPage3.html

Workshops offered byCochrane Centres in 2010

Online LearningResources

At the start of 2009 Dr David Tovey took on therole of The Cochrane Library's first Editor-in-Chief.

The Cochrane Database of Systematic Reviews(CDSR) moved to monthly publication at thebeginning of January 2010.

The following issues will be submitted forpublication on the dates below:

• Issue 7 - 17 June 2010• Issue 8 - 08 July 2010• Issue 9 - 05 August 2010• Issue 10 -09 September 2010• Issue 11 -07 October 2010• Issue 12 -11 November 2010

Cochrane Collaboration news



BackgroundStress urinary incontinence (SUI) is a commoncondition affecting up to 30% of women. Minimallyinvasive synthetic suburethral sling operations areamong the latest forms of procedures introduced totreat SUI.

ObjectivesTo assess the effects of minimally invasive syntheticsuburethral sling operations for treatment of SUI,urodynamic stress incontinence (USI) or mixed urinaryincontinence (MUI) in women.

Search strategyWe searched the Cochrane Incontinence GroupSpecialised Register (searched 20 March 2008),MEDLINE (January 1950 to April 2008), EMBASE(January 1988 to April 2008), CINAHL (January 1982to April 2008), AMED (January 1985 to April 2008),the UK National Research Register, ClinicalTrials.gov,and reference lists of relevant articles.

Selection criteriaRandomised or quasi-randomised controlled trialsamongst women with SUI, USI or symptoms of stressor mixed urinary incontinence, in which at least onetrial arm involved a minimally invasive syntheticsuburethral sling operations.

Data collection and analysisTwo review authors assessed the methodologicalquality of potentially eligible studies and independentlyextracted data from the included trials.

Main resultsSixty two trials involving 7101 women were included.The quality of evidence was moderate for most trials.Minimally invasive synthetic suburethral slingoperations appeared to be as effective as traditionalsuburethral slings ( trials, n = 599, Risk Ratio (RR) 1.03,95% Confidence Interval (CI) 0.94 to 1.13) but withshorter operating time and less post-operative voidingdysfunction and de novo urgency symptoms.

Minimally invasive synthetic suburethral slingoperations appeared to be as effective as openretropubic colposuspension (subjective cure rate at 12months RR 0.96, 95% CI 0.90 to 1.03; at 5 years RR0.91, 95% CI 0.74 to 1.12) with fewer perioperativecomplications, less postoperative voiding dysfunction,shorter operative time and hospital stay butsignificantly more bladder perforations (6% versus 1%,RR 4.24, 95% CI 1.71 to 10.52).

There was conflicting evidence about theeffectiveness of minimally invasive syntheticsuburethral sling operations compared to laparoscopiccolposuspension in the short term (objective cure, RR1.15, 95% CI 1.06 to 1.24; subjective cure RR 1.11, 95%CI 0.99 to 1.24). Minimally invasive syntheticsuburethral sling operations had significantly less denovo urgency and urgency incontinence, shorteroperating time, hospital stay and time to return to dailyactivities.

A retropubic bottom-to-top route was more effectivethan top-to-bottom route (RR 1.10, 95% CI 1.01 to 1.20;RR 1.06, 95% CI 1.01 to 1.11) and incurred significantlyless voiding dysfunction, bladder perforations and tapeerosions.

Monofilament tapes had significantly higher objectivecure rates (RR 1.15, 95% CI 1.02 to 1.30) compared tomultifilament tapes and fewer tape erosions (1.3%versus 6% RR 0.25, 95% CI 0.06 to 1.00).

The obturator route was less favourable than theretropubic route in objective cure (84% versus 88%;RR 0.96, 95% CI 0.93 to 0.99; 17 trials, n = 2434),although there was no difference in subjective curerates. However, there was less voiding dysfunction,blood loss, bladder perforation (0.3% versus 5.5%, RR0.14, 95% CI 0.07 to 0.26) and shorter operating timewith the obturator route.

Authors' conclusionsThe current evidence base suggests that minimallyinvasive synthetic suburethral sling operations are aseffective as traditional suburethral slings, openretropubic colposuspension and laparoscopiccolposuspension in the short term but with lesspostoperative complications. Objective cure rates arehigher with retropubic tapes than with obturator tapesbut retropubic tapes attract more complications. Mostof the trials had short term follow up and the qualityof the evidence was variable.

Citation: Ogah J, Cody JD, Rogerson L. Minimally invasivesynthetic suburethral sling operations for stress urinaryincontinence in women. Cochrane Database of Systematic Reviews2009, Issue 4. Art. No.: CD006375. DOI:10.1002/14651858.CD006375.pub2.

Abstract of a newly published review:Minimally invasive synthetic suburethral sling operations

for stress urinary incontinence in womenJoseph Ogah1, June D Cody2, Lynne Rogerson3



In The Cochrane Library from the Cochrane Incontinence Review Group

1. Absorbent products for light urinaryincontinence in women Fader M, Cottenden AM,Getliffe K.

2. Absorbent products for moderate-heavyurinary and/or faecal incontinence in womenand women Fader M, Cottenden AM, Getliffe K.

3. Adrenergic drugs for urinary incontinence inadults Alhasso A, Glazener CMA, Pickard R,N'Dow J.

4. Alarm interventions for nocturnal enuresis inchildren Glazener CMA, Evans JHC, Peto RE.

5. Alpha blockers prior to removal of a catheterfor acute urinary retention in adult men ZeifH-J, Subramonian K.

6. Anterior vaginal repair for urinaryincontinence in women Glazener CMA, Cooper K

7. Antibiotic policies for short-term catheterbladder drainage in adults Niël-Weise BS, vanden Broek PJ.

8. Anticholinergic drugs versus non-drug activetherapies for overactive bladder syndrome inadults Alhasso AA, Mckinlay K, Patrick K,Stewart L.

9. Anticholinergic drugs versus othermedications for overactive bladder syndromein adults Roxburgh C, Cook J, Dublin N.

10. Anticholinergic drugs versus placebo foroveractive syndrome in adults Nabi G, CodyJD, Ellis G, Hay-Smith J, Herbison P,

11. Behavioural and cognitive interventions with orwithout other treatments for the managementof faecal incontinence in children Brazzelli M,Griffiths P.

12. Biofeedback and/or sphincter exercises forthe treatment of faecal incontinence in adultsNorton C, Cody JD, Hosker G.

13. Bladder neck needle suspension for urinaryincontinence in women Glazener CMA, Cooper K.

14. Bladder training for urinary incontinence inadults Wallace SA, Roe B, Williams K, Palmer M.

15. Botulinum toxin injections for adults withoveractive bladder syndrome Duthie J, WilsonD, Herbison GP, Wilson D.

16. Catheter policies for management of longterm voiding problems in adults withneurogenic bladder disorders Jamison J,Maguire S, McCann J.

Published Cochrane Reviews 17. Complementary and miscellaneousinterventions for nocturnal enuresis inchildren Glazener CMA, Evans JHC, Cheuk DKL.

18. Complex behavioural and educationalinterventions for nocturnal enuresis inchildren Glazener CMA, Evans JHC, Peto RE.

19. Conservative management of postprostectomyurinary incontinence Hunter KF, Moore KN,Glazener CMA.

20. Conservative management of pelvic organprolapse in women Hagen S, Stark D, Maher C,Adams E.

21. Desmopressin for nocturnal enuresis inchildren Glazener CMA, Evans JHC.

22. Drug treatment for faecal incontinence inadults Cheetham MJ, Brazzeli M, Norton CC,Glazener CMA.

23. Drugs for nocturnal enuresis in children (otherthan desmopressin and tricyclics) GlazenerCMA, Evans JHC, Peto RE.

24. Electrical stimulation for faecal incontinencein adults Hosker G, Cody JD, Norton CC.

25. Habit retraining for the management ofurinary incontinence in adult Ostaszkiewicz J,Johnson L, Roe B.

26. Intravesical treatments for painful bladdersyndrome/ interstitial cystitis Dawson TE,Jamison J.

27. Laparoscopic colposuspension for urinaryincontinence in women Dean NM, Ellis G,Wilson PD, Herbison GP.

28. Long-term bladder management byintermittent catheterisation in adults andchildren Moore K, Getliffe K, Fader M.

29. Management of faecal incontinence andconstipation in adults with central neurologicaldiseases Coggrave, M, Wiesel PH, Norton CC.

30. Mechanical devices for pelvic organ prolapsein women Adams E, Thomson A, Maher C, HagenS.

31. Mechanical devices for urinary incontinence inwomen Shaikh S, Ong EK, Glavind K, Cook J,N’Dow.

32. Minimally invasive synthetic suburethral slingoperations for stress urinary incontinence inwomen. Ogah J, Cody JD, Rogerson L.



33. Oestrogens therapy for urinary incontinencein post-menopausal women Cody JD,Richardson K, Moehrer B, Hextall A, GlazenerCMA.

34. Open retropubic colposuspension for urinaryincontinence in women Lapitan MC, Cody DJ,Grant AM.

35. Pelvic floor muscle training for prevention andtreatment of urinary and faecal incontinencein antenatal and postnatal women Hay-SmithJ, Dumoulin C.

36. Pelvic floor muscle training versus notreatment, or inactive control treatments,for urinary incontinence in women Dumoulin C,Hay-Smith J.

37. Perianal injectable bulking agents astreatment for faecal incontinence Maeda Y,Laurberg S, Norton C.

38. Periurethral injection therapy for urinaryincontinence in women Keegan P, Atiemo K,McClinton S, Pickard R.

39. Plugs for containing faecal incontinenceDeutekom M, Dobben A.

40. Prompted voiding for the management ofurinary incontinence in adults Eustice S, Roe B,Paterson J.

41. Sacral nerve stimulation for faecalincontinence and constipation in adults MowattG, Glazener C, Jarrett M.

42. Sacral neuromodulation with implanted devicesfor urinary storage and voiding dysfunction inadults Herbison GP, Arnold EP.

43. Serotonin and noradrenaline reuptakeinhibitors (SNRI) for stress urinaryincontinence in adults Marriapan P, BallantyneZ, N’Dow JMO, Alhasso AA.

44. Short term urinary catheter policies followingurogenital surgery in adults Phipps S, Lim YN,McClinton S, Barry C, Rane A, N’Dow J.

45. Simple behavioural and physical interventionsfor nocturnal enuresis in children GlazenerCMA, Evans JHC.

46. Simple urethral dilatation, endoscopicurethrotomy, and urethroplasty for urethralstricture disease in adult men Wong SSW,Narahari R, O'Riordan A, Pickard R.

47. Strategies for the removal of short-termindwelling urethral catheters in adultsGriffiths R, Fernandez R.

48. Surgery for complete rectal prolapse in adultsTou S, Brown SR, Malik AIrqam, Nelson RL.

49. Surgery for faecal incontinence in adultsBrown S, Nelson R.

50. Surgical management of pelvic organ prolapsein women Maher C, Feiner B, Baessler K,Glazener CMA.

51. Timed voiding for the management of urinaryincontinence in adults Ostaszkiewicz J,Johnston L, Roe B.

52. Traditional suburethral sling operations forurinary incontinence in women Bezerra CA,Bruschini H, Cody DJ.

53. Treatment of urinary incontinence afterstroke in adults Thomas L, Barrett J, Cross S,French B, Leathley M, Sutton C, Watkins C.

54. Tricyclic and related drugs for nocturnalenuresis in children Glazener, CMA, Evans JHC,Peto RE.

55. Types of indwelling urinary catheters forlong-term bladder drainage in adults Jahn P,Preuss M, Kernig A, Seifert-Hühmer A, LangerG.

56. Types of urethral catheters for managementof short-term voiding problems in hospitalisedadults Schumm K, Lam TBL.

57. Urinary catheter policies for long-termbladder drainage Niel-Weise BS, van den BroekPJ.

58. Urinary catheter policies for short-termbladder drainage in adults Niël-Weise BS, vanden Broek PJ.

59. Urinary diversion and bladder reconstruction/replacement using intestinal segments forintractable incontinence or followingcystectomy Nabi G, Cody J, Dublin N, McClintonS, N’Dow JMO, Neal DE, Pickard R, Yong SM.

60. Urodynamic investigations for management ofurinary incontinence in children and adultsGlazener CMA, Lapitan MC.

61. Washout policies in long-term indwellingurinary catheterization in adults. Hagen S,Sinclair L, Cross S.

62. Weighted vaginal cones for urinaryincontinence Herbison P, Dean N.

63. Which anticholinergic drug for overactivebladder symptoms in adults Hay-Smith J,Herbison P, Ellis G, Morris A.



Key DatesEarly registration closes 6 JulyMeeting room requests ends 9 AugustHotel registration ends 7 SeptemberCancellation deadlines 13 SeptemberColloquium 18-22 OctoberFor more details visit the website:www.regonline.com/builder/site/default.aspx?eventid=766689

1. Acupuncture for bladder dysfunction after spinalcord injury Jiaqi W, Sung L, Yu J, Zhishun L.

2. Acupuncture for urinary incontinence in adultswithout neurological disease Sung LM, Jiaqi W.

3. Conservative management of nocturia in adultsReynard J, Cannon A, Abrams P.

4. Drugs for nocturia in adults Cannon A, Abrams P,Reynard J.

5. Drugs for treatment of urinary retention aftersurgery in adults. Buckley BS, Lapitan MCM.

6. Electromagnetic treatment for adult urinaryincontinence Khazali S, Jackson S, Balmforth S.

7. Lifestyle interventions for the treatment of urinaryincontinence in adults Nygaard I, Bryant C, Dowell C,Wilson PD.

8. Medical treatments for painful bladder syndrome(interstitial cystitis) Jamieson J, Dawson T, HelfandM.

9. Oestrogens for treatment or prevention of pelvicorgan prolapse in women Ismail SI, Bain C, Hagen S.

10. Pelvic floor muscle training in combination withanother therapy compared with the other therapyalone for urinary incontinence in women Kovoor E,Datta S, Patel A.

11. Pelvic floor muscle training versus other activetreatments for urinary incontinence in women PatelA, Datta S, Kovoor E.

12. Prohylactic antibiotics to reduce risk of urinarytract infection after urodynamic studies Latthe P,Foon R, Toozs-Hobson P.

13. Surgery for urinary incontinence due to presumedsphincter deficiency after prostate surgery SilvaLA, Andriolo RB, Atallah ÁN, da Silva EMK.

Published Cochrane Protocols

Join over 2,000 professionals specializing in uro-gynaecology and related fields at ICS-IUGA 2010.Expand your knowledge during a multi-disciplinaryscientific program with presentations frominternationally acclaimed experts in continenceresearch and treatment, abstract and posterpresentations, roundtable discussions, meet theexpert sessions, networking opportunities and more.

We will have an exhibition stand at The MetroToronto Convention Centre stand number 50. Wewould be very glad to meet as many of you as possibleat the stand. The Cochrane Library will bedemonstrated and available to browse.

For more details visit the website:www2.kenes.com/ics2010/Pages/Home.aspx

Joint Annual Meeting of theInternational Continence Society (ICS)and International Urogynaecological

Association (IUGA)23 - 27 August 2010, Toronto, Canada

The University of Colorado Denver is proud to behosting the first Joint Colloquium of the Cochrane &Campbell Collaborations in Keystone, Colorado on 18-22 October, 2010.

This colloquium will focus on raising evidence-baseddecision-making to new heights. In this region, knownfor its towering mountain peaks and natural beauty,we will come together for multidisciplinary learningand sharing at its best.

Keystone Resort is located in the famous ColoradoRocky Mountains. Please note that it is a highaltitude resort at 9500 ft (~2800 m). Your visit willbe a time to relax & enjoy the outdoors whileenriching your mind and catching up with colleaguesfrom across the globe.

Joint Colloquium of the Cochrane &Campbell Collaborations,

18 -20 October 2010, Colorado, USA.



Australasian Cochrane CentreTel: +61 3 9594 7530Fax: +61 3 9594 7554Email: [email protected] Cochrane CentreTel: +55 11 5575 2970Fax: +55 11 5579 0469Email: [email protected] Cochrane CentreTel: +1 416 927 2027 ext2193Fax: +1 416 927 4167Email: [email protected] Cochrane CentreTel: +86 288 542 2078/9Fax: +86 288 542 2253/558 2944E-mail: [email protected]

Cochrane Centres Worldwide

Dutch Cochrane CentreTel: +31 20 566 5602Fax: +31 20 691 2683Email: [email protected] Cochrane CentreTel: +49 761 203 6715Fax: +49 761 203 6712Email: [email protected] Cochrane CentreTel: +34 93 291 9526/7Fax: +34 93 291 9525Email: [email protected] Cochrane CentreTel: +39 02 3901 4 ext512Fax: +39 02 355 9048Email: [email protected]

EDITORIAL MEETING, in Paris, July 2008.From left to right: Back row James N’Dow, Peter Herbison, Brian Buckley, Marie Carmela Lapitan, Katherine MooreFront row: June Cody, Sheila Wallace, Mandy Fader, Jean Hay-Smith. Not present are: Jonathan Cook, Nicola Dean,

Cathryn Glazener, Christine Norton, Rob Pickard, Don Wilson.

Editorial Base Staff, AberdeenJune Cody Managing EditorEmail: [email protected] Glazener Joint Co-ordinating Editor, AberdeenEmail: [email protected] N’Dow Joint Co-ordinating Editor, AberdeenEmail: [email protected] Wallace Trials Search Co-ordinatorEmail: [email protected] Davidson SecretaryEmail: [email protected]

Editors:Brian BuckleyEmail: [email protected] Cook Aberdeen, UKEmail: [email protected]

Nicola Dean York, UKEmail: [email protected] Fader Southampton, UKEmail: [email protected] Hay-Smith Otago, New ZealandEmail: [email protected] Herbison Statistics and Criticism EditorOtago, New ZealandEmail: [email protected] Carmela Lapitan Manila, PhilippinesEmail: [email protected] Moore Edmonton CanadaEmail: [email protected] Norton London, UKEmail: [email protected] PickardEmail: [email protected] Wilson Otago, New ZealandEmail: [email protected]

Nordic Cochrane CentreTel: +45 3545 7112Fax: +45 3545 7007Email: [email protected] African Cochrane CentreTel: +27 21 938 0438Fax: +27 21 938 0836Email: [email protected] Cochrane CentreTel: +44 1865 516300Fax: +44 1865 516311Email: [email protected] Cochrane CenterTel: +1 401 502 4640Fax: +1 401 502 4621E-mail: [email protected]

Return unwanted copies of Cochrane Newsletter to:Cochrane Incontinence Group, Academic Urology Unit,University of Aberdeen, 2nd Floor Health Sciences Building,Foresterhill, Aberdeen AB25 2ZD, Scotland, UK

THE COCHRANECOLLABORATION



Please photocopy, complete and return the following section if:• Your contact details have changed and you wish to be kept informed about our group• You are not on our mailing list and you would like to receive information about our group• You would like to be removed from our mailing list

Name:

Job title/position:

Address:

Telephone (please include international and area codes):

Fax:

E-mail address:

Professional interests (in brief):

Interests relevant to our group (if different to above):

Proposed contribution to our group, if any (e.g. developing a review (give area); handsearching, peerreview, translation to english):

I would like to receive future postal mailings: Yes/No

Cochrane Incontinence Group, Academic Urology Unit, University of Aberdeen,2nd Floor Health Sciences Building, Aberdeen, AB25 2ZD, UK

Tel: +44 1224 559244 Fax: +44 1224 554580 E-mail: j.cody:abdn.ac.uk

Contact Details

Documents

Newsletter 2010 - Cochrane Incontinence Group - The Cochrane